Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The core trial purpose wording was clarified to compare relatlimab+nivolumab with nivolumab monotherapy; an EU CT Number was added and the old EudraCT Number replaced, along with a new MedlinePlus link and updated revision/date stamps.
    Difference
    1%
    Check dated 2025-09-15T00:21:10.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to version 3.0.1, and the section on Melanoma related topics from MedlinePlus Genetics has been removed.
    Difference
    0.3%
    Check dated 2025-09-07T20:49:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new MedlinePlus related topics on melanoma and cancer immunotherapy. Additionally, several references to studies and articles related to advanced melanoma treatments have been included.
    Difference
    17%
    Check dated 2025-08-31T13:45:01.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T12:26:25.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T08:37:20.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-03T03:10:40.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.